메뉴 건너뛰기




Volumn 15, Issue 3, 2011, Pages 230-237

The role of brachytherapy in the definitive management of prostate cancer

Author keywords

High dose rate; Low dose rate; Prostate brachytherapy

Indexed keywords

CESIUM 137; IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN; TAMSULOSIN; TERAZOSIN;

EID: 79956190240     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2011.01.004     Document Type: Short Survey
Times cited : (43)

References (97)
  • 1
    • 73949130115 scopus 로고    scopus 로고
    • Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    • Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
    • (2010) J Clin Oncol , vol.28 , pp. 126-131
    • Klotz, L.1    Zhang, L.2    Lam, A.3    Nam, R.4    Mamedov, A.5    Loblaw, A.6
  • 2
    • 77951298004 scopus 로고    scopus 로고
    • Cryotherapy for prostate cancer: ready for prime time?
    • Pisters L.L. Cryotherapy for prostate cancer: ready for prime time?. Curr Opin Urol 2010, 20:218-222.
    • (2010) Curr Opin Urol , vol.20 , pp. 218-222
    • Pisters, L.L.1
  • 4
    • 27244436839 scopus 로고    scopus 로고
    • Technology review: high-intensity focused ultrasound for prostate cancer
    • Pickles T., Goldenberg L., Steinhoff G. Technology review: high-intensity focused ultrasound for prostate cancer. Can J Urol 2005, 12:2593-2597.
    • (2005) Can J Urol , vol.12 , pp. 2593-2597
    • Pickles, T.1    Goldenberg, L.2    Steinhoff, G.3
  • 5
    • 0034891284 scopus 로고    scopus 로고
    • High dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer
    • Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
    • (2001) J Urol , vol.166 , pp. 876-881
    • Zelefsky, M.J.1    Fuks, Z.2    Hunt, M.3    Lee, H.J.4    Lombardi, D.5    Ling, C.C.6
  • 6
    • 45449093563 scopus 로고    scopus 로고
    • Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
    • Zelefsky M.J., Yamada Y., Fuks Z., Zhang Z., Hunt M., Cahlon O., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71:1028-1033.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , pp. 1028-1033
    • Zelefsky, M.J.1    Yamada, Y.2    Fuks, Z.3    Zhang, Z.4    Hunt, M.5    Cahlon, O.6
  • 8
    • 49549085535 scopus 로고    scopus 로고
    • Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer
    • Chan L.W., Xia P., Gottschalk A.R., Akazawa M., Scala M., Pickett B., et al. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 72:69-77.
    • (2008) Int J Radiat Oncol Biol Phys. , vol.72 , pp. 69-77
    • Chan, L.W.1    Xia, P.2    Gottschalk, A.R.3    Akazawa, M.4    Scala, M.5    Pickett, B.6
  • 11
    • 79955596938 scopus 로고    scopus 로고
    • Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer
    • [in press]. doi:10.1016/j.ijrobp.2010.02.040
    • Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.02.040.
    • (2010) Int J Radiat Oncol Biol Phys
    • Sharma, N.K.1    Li, T.2    Chen, D.Y.3    Pollack, A.4    Horwitz, E.M.5    Buyyounouski, M.K.6
  • 12
    • 0015474752 scopus 로고
    • Retropubic implantation to iodine 125 in the treatment of prostatic cancer
    • Whitmore W.F., Hilaris B., Grabstald H. Retropubic implantation to iodine 125 in the treatment of prostatic cancer. J Urol. 1972, 108:918-920.
    • (1972) J Urol. , vol.108 , pp. 918-920
    • Whitmore, W.F.1    Hilaris, B.2    Grabstald, H.3
  • 13
    • 0030764130 scopus 로고    scopus 로고
    • Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
    • Ragde H., Blasko J.C., Grimm P.D., Kenny G.M., Sylvester J.E., Hoak D.C., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 1997, 80:442-453.
    • (1997) Cancer. , vol.80 , pp. 442-453
    • Ragde, H.1    Blasko, J.C.2    Grimm, P.D.3    Kenny, G.M.4    Sylvester, J.E.5    Hoak, D.C.6
  • 14
    • 33645101180 scopus 로고    scopus 로고
    • Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy
    • Martens C., Pond G., Webster D., McLean M., Gillan C., Crook J. Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. Brachytherapy. 2006, 5:9-13.
    • (2006) Brachytherapy. , vol.5 , pp. 9-13
    • Martens, C.1    Pond, G.2    Webster, D.3    McLean, M.4    Gillan, C.5    Crook, J.6
  • 15
    • 0036471475 scopus 로고    scopus 로고
    • Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation
    • Crook J., McLean M., Catton C., Yeung I., Tsihlias J., Pintilie M. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002, 52:453-460.
    • (2002) Int J Radiat Oncol Biol Phys. , vol.52 , pp. 453-460
    • Crook, J.1    McLean, M.2    Catton, C.3    Yeung, I.4    Tsihlias, J.5    Pintilie, M.6
  • 16
    • 0036499149 scopus 로고    scopus 로고
    • Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study
    • Locke J., Ellis W., Wallner K., Cavanagh W., Blasko J. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys. 2002, 52:712-719.
    • (2002) Int J Radiat Oncol Biol Phys. , vol.52 , pp. 712-719
    • Locke, J.1    Ellis, W.2    Wallner, K.3    Cavanagh, W.4    Blasko, J.5
  • 17
    • 0034564113 scopus 로고    scopus 로고
    • Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy
    • Lee N., Wuu C.S., Brody R., Laguna J.L., Katz A.E., Bagiella E., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000, 48:1457-1460.
    • (2000) Int J Radiat Oncol Biol Phys. , vol.48 , pp. 1457-1460
    • Lee, N.1    Wuu, C.S.2    Brody, R.3    Laguna, J.L.4    Katz, A.E.5    Bagiella, E.6
  • 21
    • 34648843753 scopus 로고    scopus 로고
    • Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy
    • Mabjeesh N.J., Chen J., Stenger A., Matzkin H. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Urology. 2007, 70:548-553.
    • (2007) Urology. , vol.70 , pp. 548-553
    • Mabjeesh, N.J.1    Chen, J.2    Stenger, A.3    Matzkin, H.4
  • 22
    • 0026591918 scopus 로고
    • The american urological association symptom index for benign prostatic hyperplasia. the measurement committee of the american urological association
    • [discussion 1564]
    • Barry M.J., Fowler F.J., O'Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., et al. The american urological association symptom index for benign prostatic hyperplasia. the measurement committee of the american urological association. J Urol. 1992, 148:1549-1557. [discussion 1564].
    • (1992) J Urol. , vol.148 , pp. 1549-1557
    • Barry, M.J.1    Fowler, F.J.2    O'Leary, M.P.3    Bruskewitz, R.C.4    Holtgrewe, H.L.5    Mebust, W.K.6
  • 25
    • 37049023855 scopus 로고    scopus 로고
    • Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy
    • Nag S., Shi P., Liu B., Gupta N., Bahnson R.R., Wang J.Z. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008, 70:311-317.
    • (2008) Int J Radiat Oncol Biol Phys. , vol.70 , pp. 311-317
    • Nag, S.1    Shi, P.2    Liu, B.3    Gupta, N.4    Bahnson, R.R.5    Wang, J.Z.6
  • 26
    • 77954959954 scopus 로고    scopus 로고
    • Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy
    • Ishiyama H., Nakamura R., Satoh T., Tanji S., Uemae M., Baba S., et al. Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy. Brachytherapy. 2010, 9:219-223.
    • (2010) Brachytherapy. , vol.9 , pp. 219-223
    • Ishiyama, H.1    Nakamura, R.2    Satoh, T.3    Tanji, S.4    Uemae, M.5    Baba, S.6
  • 27
    • 57749169963 scopus 로고    scopus 로고
    • Comparison between real-time intraoperative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131
    • Jacobs B.L., Gibbons E.P., Smith R.P., Beriwal S., Komanduri K., Benoit R.M. Comparison between real-time intraoperative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131. Technol Cancer Res Treat. 2008, 7:463-469.
    • (2008) Technol Cancer Res Treat. , vol.7 , pp. 463-469
    • Jacobs, B.L.1    Gibbons, E.P.2    Smith, R.P.3    Beriwal, S.4    Komanduri, K.5    Benoit, R.M.6
  • 28
    • 70350712610 scopus 로고    scopus 로고
    • AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of task group 137
    • Nath R., Bice W.S., Butler W.M., Chen Z., Meigooni A.S., Narayana V., et al. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of task group 137. Med Phys. 2009, 36:5310-5322.
    • (2009) Med Phys. , vol.36 , pp. 5310-5322
    • Nath, R.1    Bice, W.S.2    Butler, W.M.3    Chen, Z.4    Meigooni, A.S.5    Narayana, V.6
  • 29
    • 33646267933 scopus 로고    scopus 로고
    • Rectal-wall dose dependence on postplan timing after permanent seed prostate brachytherapy
    • Taussky D., Yeung I., Williams T., Pearson S., McLean M., Pond G., et al. Rectal-wall dose dependence on postplan timing after permanent seed prostate brachytherapy. Radiat Oncol Biol Phys. 2006, 65:358-363.
    • (2006) Radiat Oncol Biol Phys. , vol.65 , pp. 358-363
    • Taussky, D.1    Yeung, I.2    Williams, T.3    Pearson, S.4    McLean, M.5    Pond, G.6
  • 31
    • 57649112761 scopus 로고    scopus 로고
    • Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer
    • Saibishkumar E.P., Borg J., Yeung I., Cummins-Holder C., Landon A., Crook J. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009, 73:61-68.
    • (2009) Int J Radiat Oncol Biol Phys. , vol.73 , pp. 61-68
    • Saibishkumar, E.P.1    Borg, J.2    Yeung, I.3    Cummins-Holder, C.4    Landon, A.5    Crook, J.6
  • 32
    • 21244455123 scopus 로고    scopus 로고
    • Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion
    • Taussky D., Austen L., Toi A., Yeung I., Williams T., Pearson S., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys. 2005, 62:974-980.
    • (2005) Int J Radiat Oncol Biol Phys. , vol.62 , pp. 974-980
    • Taussky, D.1    Austen, L.2    Toi, A.3    Yeung, I.4    Williams, T.5    Pearson, S.6
  • 33
    • 0344234456 scopus 로고    scopus 로고
    • Importance of implant dosimetry for patients undergoing prostate brachytherapy
    • Potters L., Huang D., Calugaru E., Fearn P., Lee L., Kattan M.W. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology. 2003, 62:1073-1077.
    • (2003) Urology. , vol.62 , pp. 1073-1077
    • Potters, L.1    Huang, D.2    Calugaru, E.3    Fearn, P.4    Lee, L.5    Kattan, M.W.6
  • 34
    • 30544440136 scopus 로고    scopus 로고
    • Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results
    • Stock R.G., Stone N.N., Cesaretti J.A., Rosenstein B.S. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006, 64:527-533.
    • (2006) Int J Radiat Oncol Biol Phys. , vol.64 , pp. 527-533
    • Stock, R.G.1    Stone, N.N.2    Cesaretti, J.A.3    Rosenstein, B.S.4
  • 36
    • 77956535585 scopus 로고    scopus 로고
    • Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90)≥180gy
    • Gomez-Iturriaga Pina A., Crook J., Borg J., Ma C. Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90)≥180gy. Int J Radiat Oncol Biol Phys. 2010, 78:422-427.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.78 , pp. 422-427
    • Gomez-Iturriaga Pina, A.1    Crook, J.2    Borg, J.3    Ma, C.4
  • 37
    • 25144518567 scopus 로고    scopus 로고
    • Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk
    • Crook J.M., Potters L., Stock R.G., Zelefsky M.J. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. Brachytherapy. 2005, 4:186-194.
    • (2005) Brachytherapy. , vol.4 , pp. 186-194
    • Crook, J.M.1    Potters, L.2    Stock, R.G.3    Zelefsky, M.J.4
  • 38
    • 0035371057 scopus 로고    scopus 로고
    • Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis
    • Snyder K.M., Stock R.G., Hong S.M., Lo Y.C., Stone N.N. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001, 50:335-341.
    • (2001) Int J Radiat Oncol Biol Phys. , vol.50 , pp. 335-341
    • Snyder, K.M.1    Stock, R.G.2    Hong, S.M.3    Lo, Y.C.4    Stone, N.N.5
  • 39
    • 0042383238 scopus 로고    scopus 로고
    • Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
    • Lee H.K., D'Souza W.D., Yamal J.M., Pollack A., Lee A.K., Palmer M.B., et al. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003, 57:355-361.
    • (2003) Int J Radiat Oncol Biol Phys. , vol.57 , pp. 355-361
    • Lee, H.K.1    D'Souza, W.D.2    Yamal, J.M.3    Pollack, A.4    Lee, A.K.5    Palmer, M.B.6
  • 40
    • 33646940462 scopus 로고    scopus 로고
    • Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography
    • Gillan C., Kirilova A., Landon A., Yeung I., Pond G., Crook J. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography. Int J Radiat Oncol Biol Phys. 2006, 65:688-693.
    • (2006) Int J Radiat Oncol Biol Phys. , vol.65 , pp. 688-693
    • Gillan, C.1    Kirilova, A.2    Landon, A.3    Yeung, I.4    Pond, G.5    Crook, J.6
  • 42
    • 79956213141 scopus 로고    scopus 로고
    • Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
    • [in press]. doi:10.1016/j.brachy.2010.10.001
    • Usmani N, Chng N, Spadinger I, Morris WJ. Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants. Brachytherapy 2010; [in press]. doi:10.1016/j.brachy.2010.10.001.
    • (2010) Brachytherapy
    • Usmani, N.1    Chng, N.2    Spadinger, I.3    Morris, W.J.4
  • 43
    • 73649141319 scopus 로고    scopus 로고
    • Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy
    • McLaughlin P.W., Evans C., Feng M., Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys. 2010, 76:369-378.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.76 , pp. 369-378
    • McLaughlin, P.W.1    Evans, C.2    Feng, M.3    Narayana, V.4
  • 44
    • 10744220937 scopus 로고    scopus 로고
    • Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy
    • Crook J., Milosevic M., Catton P., Yeung I., Haycocks T., Tran T., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy. 2002, 1:66-73.
    • (2002) Brachytherapy. , vol.1 , pp. 66-73
    • Crook, J.1    Milosevic, M.2    Catton, P.3    Yeung, I.4    Haycocks, T.5    Tran, T.6
  • 46
    • 79956196511 scopus 로고    scopus 로고
    • Implications of CT-imaging for post plan quality assessment (QA) in prostate brachytherapy (BT) (poster). ESTRO 29; September 12-16, 2010; Barcelona, Spain;
    • Petrik D, Crook J, Araujo C, Halperin R, Kim D. In: Implications of CT-imaging for post plan quality assessment (QA) in prostate brachytherapy (BT) (poster). ESTRO 29; September 12-16, 2010; Barcelona, Spain; 2010. p. S216.
    • (2010)
    • Petrik, D.1    Crook, J.2    Araujo, C.3    Halperin, R.4    Kim, D.5
  • 47
    • 77953547920 scopus 로고    scopus 로고
    • Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy
    • Crook J., Patil N., Ma C., McLean M., Borg J. Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2010, 77:1079-1084.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.77 , pp. 1079-1084
    • Crook, J.1    Patil, N.2    Ma, C.3    McLean, M.4    Borg, J.5
  • 48
    • 79960077352 scopus 로고    scopus 로고
    • 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients
    • [in press]. doi:10.1016/j.ijrobp.2010.04.038
    • Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, et al. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.038.
    • (2010) Int J Radiat Oncol Biol Phys
    • Crook, J.1    Borg, J.2    Evans, A.3    Toi, A.4    Saibishkumar, E.P.5    Fung, S.6
  • 49
    • 4644354413 scopus 로고    scopus 로고
    • Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications
    • Peschel R.E, Colberg J.W., Chen Z., Nath R., Wilson L.D. Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J 2004, 10:170-174.
    • (2004) Cancer J , vol.10 , pp. 170-174
    • Peschel, R.E.1    Colberg, J.W.2    Chen, Z.3    Nath, R.4    Wilson, L.D.5
  • 50
    • 0344395011 scopus 로고    scopus 로고
    • 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial
    • Wallner K., Merrick G., True L., Sutlief S., Cavanagh W., Butler W. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 2003, 57:1297-1303.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 1297-1303
    • Wallner, K.1    Merrick, G.2    True, L.3    Sutlief, S.4    Cavanagh, W.5    Butler, W.6
  • 51
    • 79956208938 scopus 로고    scopus 로고
    • Predictors of urinary morbidity in cs-131 prostate brachytherapy implants
    • [in press]. doi:10.1016/j.ijrobp.2010.06.017
    • Smith RP, Jones HA, Beriwal S, Gokhale A, Benoit R. Predictors of urinary morbidity in cs-131 prostate brachytherapy implants. Int J Radiat Oncol Biol Phys 2010, [in press]. doi:10.1016/j.ijrobp.2010.06.017.
    • (2010) Int J Radiat Oncol Biol Phys
    • Smith, R.P.1    Jones, H.A.2    Beriwal, S.3    Gokhale, A.4    Benoit, R.5
  • 52
  • 54
    • 67349130809 scopus 로고    scopus 로고
    • Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy
    • Stock R.G., Klein T.J., Cesaretti J.A., Stone N.N. Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2009, 74:753-758.
    • (2009) Int J Radiat Oncol Biol Phys. , vol.74 , pp. 753-758
    • Stock, R.G.1    Klein, T.J.2    Cesaretti, J.A.3    Stone, N.N.4
  • 56
    • 73649090388 scopus 로고    scopus 로고
    • Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes
    • Stone N.N., Stock R.G., Cesaretti J.A., Unger P. Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes. Int J Radiat Oncol Biol Phys. 2010, 76:355-360.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.76 , pp. 355-360
    • Stone, N.N.1    Stock, R.G.2    Cesaretti, J.A.3    Unger, P.4
  • 57
    • 34147146526 scopus 로고    scopus 로고
    • Patterns of local failure following prostate brachytherapy
    • [discussion 1763-4]
    • Stone N.N., Stock R.G., White I., Unger P. Patterns of local failure following prostate brachytherapy. J Urol. 2007, 177:1759-1763. [discussion 1763-4].
    • (2007) J Urol. , vol.177 , pp. 1759-1763
    • Stone, N.N.1    Stock, R.G.2    White, I.3    Unger, P.4
  • 58
    • 63149196150 scopus 로고    scopus 로고
    • Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer
    • [discussion 865-7]
    • Morris W.J., Keyes M., Palma D., Spadinger I., McKenzie M.R., Agranovich A., et al. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology. 2009, 73:860-865. [discussion 865-7].
    • (2009) Urology. , vol.73 , pp. 860-865
    • Morris, W.J.1    Keyes, M.2    Palma, D.3    Spadinger, I.4    McKenzie, M.R.5    Agranovich, A.6
  • 59
    • 0242523827 scopus 로고    scopus 로고
    • No apparent benefit at 5years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose
    • Martinez A., Galalae R., Gonzalez J., Mitchell C., Gustafson G., Kovacs G. No apparent benefit at 5years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose. J Urol. 2003, 170:2296-2301.
    • (2003) J Urol. , vol.170 , pp. 2296-2301
    • Martinez, A.1    Galalae, R.2    Gonzalez, J.3    Mitchell, C.4    Gustafson, G.5    Kovacs, G.6
  • 60
    • 79959331135 scopus 로고    scopus 로고
    • Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer
    • [in press]. doi:10.1016/j.ijrobp.2010.04.004
    • Krauss D, Kestin L, Ye H, Brabbins D, Ghilezan M, Gustafson G, et al. Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.004.
    • (2010) Int J Radiat Oncol Biol Phys
    • Krauss, D.1    Kestin, L.2    Ye, H.3    Brabbins, D.4    Ghilezan, M.5    Gustafson, G.6
  • 61
    • 77952552938 scopus 로고    scopus 로고
    • Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: the Hotel-Dieu of Quebec experience
    • Zebentout O, Apardian R., Beaulieu L., Harel F., Martin A.G., Vigneault E. Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: the Hotel-Dieu of Quebec experience. Cancer Radiother 2010, 14:183-188.
    • (2010) Cancer Radiother , vol.14 , pp. 183-188
    • Zebentout, O.1    Apardian, R.2    Beaulieu, L.3    Harel, F.4    Martin, A.G.5    Vigneault, E.6
  • 62
    • 58149327450 scopus 로고    scopus 로고
    • Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy
    • Stone N.N., Potters L., Davis B.J., Ciezki J.P., Zelefsky M.J., Roach M., et al. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009, 73:341-346.
    • (2009) Int J Radiat Oncol Biol Phys. , vol.73 , pp. 341-346
    • Stone, N.N.1    Potters, L.2    Davis, B.J.3    Ciezki, J.P.4    Zelefsky, M.J.5    Roach, M.6
  • 63
    • 36749054178 scopus 로고    scopus 로고
    • Long-term urinary sequelae following 125iodine prostate brachytherapy
    • [discussion 146]
    • Crook J., Fleshner N., Roberts C., Pond G. Long-term urinary sequelae following 125iodine prostate brachytherapy. J Urol. 2008, 179:141-145. [discussion 146].
    • (2008) J Urol. , vol.179 , pp. 141-145
    • Crook, J.1    Fleshner, N.2    Roberts, C.3    Pond, G.4
  • 65
    • 61349085409 scopus 로고    scopus 로고
    • Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients
    • Keyes M., Miller S., Moravan V., Pickles T., McKenzie M., Pai H., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2009, 73:1023-1032.
    • (2009) Int J Radiat Oncol Biol Phys. , vol.73 , pp. 1023-1032
    • Keyes, M.1    Miller, S.2    Moravan, V.3    Pickles, T.4    McKenzie, M.5    Pai, H.6
  • 66
  • 67
    • 0031036150 scopus 로고    scopus 로고
    • Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
    • Crook J.M., Bahadur Y.A., Robertson S.J., Perry G.A., Esche B.A. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer. 1997, 79:81-89.
    • (1997) Cancer. , vol.79 , pp. 81-89
    • Crook, J.M.1    Bahadur, Y.A.2    Robertson, S.J.3    Perry, G.A.4    Esche, B.A.5
  • 68
    • 0141449256 scopus 로고    scopus 로고
    • Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy
    • Reed D., Wallner K., Merrick G., Buskirk S., True L. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology. 2003, 62:683-688.
    • (2003) Urology. , vol.62 , pp. 683-688
    • Reed, D.1    Wallner, K.2    Merrick, G.3    Buskirk, S.4    True, L.5
  • 71
    • 33749639088 scopus 로고    scopus 로고
    • Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
    • Horwitz E.M., Levy L.B., Thames H.D., Kupelian P.A., Martinez A.A., Michalski J.M., et al. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. Cancer. 2006, 107:1496-1502.
    • (2006) Cancer. , vol.107 , pp. 1496-1502
    • Horwitz, E.M.1    Levy, L.B.2    Thames, H.D.3    Kupelian, P.A.4    Martinez, A.A.5    Michalski, J.M.6
  • 72
    • 77952744809 scopus 로고    scopus 로고
    • Median 5-year follow-up of (125)iodine brachytherapy as monotherapy in men aged≤55years with favorable prostate cancer
    • Gomez-Iturriaga Pina A., Crook J., Borg J., Lockwood G., Fleshner N. Median 5-year follow-up of (125)iodine brachytherapy as monotherapy in men aged≤55years with favorable prostate cancer. Urology 2010, 75:1412-1416.
    • (2010) Urology , vol.75 , pp. 1412-1416
    • Gomez-Iturriaga Pina, A.1    Crook, J.2    Borg, J.3    Lockwood, G.4    Fleshner, N.5
  • 73
    • 59849088946 scopus 로고    scopus 로고
    • An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome
    • Bachand F., Martin A.G., Beaulieu L., Harel F., Vigneault E. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. Int J Radiat Oncol Biol Phys. 2009, 73:679-684.
    • (2009) Int J Radiat Oncol Biol Phys. , vol.73 , pp. 679-684
    • Bachand, F.1    Martin, A.G.2    Beaulieu, L.3    Harel, F.4    Vigneault, E.5
  • 74
    • 54049137994 scopus 로고    scopus 로고
    • High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer
    • Sato M., Mori T., Shirai S., Kishi K., Inagaki T., Hara I. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 72:1002-1009.
    • (2008) Int J Radiat Oncol Biol Phys. , vol.72 , pp. 1002-1009
    • Sato, M.1    Mori, T.2    Shirai, S.3    Kishi, K.4    Inagaki, T.5    Hara, I.6
  • 75
    • 34548043496 scopus 로고    scopus 로고
    • Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results
    • Duchesne G.M., Williams S.G., Das R., Tai K.H. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results. Radiother Oncol. 2007, 84:128-134.
    • (2007) Radiother Oncol. , vol.84 , pp. 128-134
    • Duchesne, G.M.1    Williams, S.G.2    Das, R.3    Tai, K.H.4
  • 76
    • 16344388273 scopus 로고    scopus 로고
    • High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results
    • Demanes D.J., Rodriguez R.R., Schour L., Brandt D., Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005, 61:1306-1316.
    • (2005) Int J Radiat Oncol Biol Phys. , vol.61 , pp. 1306-1316
    • Demanes, D.J.1    Rodriguez, R.R.2    Schour, L.3    Brandt, D.4    Altieri, G.5
  • 77
    • 12144291223 scopus 로고    scopus 로고
    • Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer
    • Galalae R.M., Martinez A., Mate T., Mitchell C., Edmundson G., Nuernberg N., et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004, 58:1048-1055.
    • (2004) Int J Radiat Oncol Biol Phys. , vol.58 , pp. 1048-1055
    • Galalae, R.M.1    Martinez, A.2    Mate, T.3    Mitchell, C.4    Edmundson, G.5    Nuernberg, N.6
  • 80
    • 22144492906 scopus 로고    scopus 로고
    • Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime
    • Martinez A.A., Demanes D.J., Galalae R., Vargas C., Bertermann H., Rodriguez R., et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys. 2005, 62:1322-1331.
    • (2005) Int J Radiat Oncol Biol Phys. , vol.62 , pp. 1322-1331
    • Martinez, A.A.1    Demanes, D.J.2    Galalae, R.3    Vargas, C.4    Bertermann, H.5    Rodriguez, R.6
  • 81
    • 14744292134 scopus 로고    scopus 로고
    • Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer
    • Astrom L., Pedersen D., Mercke C., Holmang S., Johansson K.A. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol. 2005, 74:157-161.
    • (2005) Radiother Oncol. , vol.74 , pp. 157-161
    • Astrom, L.1    Pedersen, D.2    Mercke, C.3    Holmang, S.4    Johansson, K.A.5
  • 82
    • 75949114376 scopus 로고    scopus 로고
    • Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The polyclinique Courlancy experience
    • Mallet F., Wdowczyk D., Bruna A., Villena P., Herard A., Amory J.P., et al. Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The polyclinique Courlancy experience. Cancer Radiother. 2010, 14:11-18.
    • (2010) Cancer Radiother. , vol.14 , pp. 11-18
    • Mallet, F.1    Wdowczyk, D.2    Bruna, A.3    Villena, P.4    Herard, A.5    Amory, J.P.6
  • 83
    • 79960087306 scopus 로고    scopus 로고
    • Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer
    • [in press]. doi:10.1016/j.ijrobp.2010.04.046
    • Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, et al. Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; [in press]. doi:10.1016/j.ijrobp.2010.04.046.
    • (2010) Int J Radiat Oncol Biol Phys
    • Morton, G.C.1    Loblaw, D.A.2    Chung, H.3    Tsang, G.4    Sankreacha, R.5    Deabreu, A.6
  • 84
    • 77952573175 scopus 로고    scopus 로고
    • Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life
    • Morton G.C, Loblaw D.A., Sankreacha R., Deabreu A., Zhang L., Mamedov A., et al. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys 2010, 77:811-817.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , pp. 811-817
    • Morton, G.C.1    Loblaw, D.A.2    Sankreacha, R.3    Deabreu, A.4    Zhang, L.5    Mamedov, A.6
  • 85
    • 58149490954 scopus 로고    scopus 로고
    • Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
    • Ghadjar P., Keller T., Rentsch C.A., Isaak B., Behrensmeier F., Stroux A., et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy. 2009, 8:45-51.
    • (2009) Brachytherapy. , vol.8 , pp. 45-51
    • Ghadjar, P.1    Keller, T.2    Rentsch, C.A.3    Isaak, B.4    Behrensmeier, F.5    Stroux, A.6
  • 86
    • 0036720256 scopus 로고    scopus 로고
    • Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy the predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate ca
    • Kestin L.L., Goldstein N.S., Vicini F.A., Mitchell C., Gustafson G.S., Stromberg J.S., et al. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy the predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial A phase II study of localized prostate cancer treated to 75.6gy with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2002, 54:107-118.
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 107-118
    • Kestin, L.L.1    Goldstein, N.S.2    Vicini, F.A.3    Mitchell, C.4    Gustafson, G.S.5    Stromberg, J.S.6
  • 87
    • 38049120408 scopus 로고    scopus 로고
    • Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer
    • Kim Y., Hsu I.C., Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007, 8:2415.
    • (2007) J Appl Clin Med Phys. , vol.8 , pp. 2415
    • Kim, Y.1    Hsu, I.C.2    Pouliot, J.3
  • 88
    • 1542346475 scopus 로고    scopus 로고
    • Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy
    • Mullokandov E., Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2004, 58:1063-1071.
    • (2004) Int J Radiat Oncol Biol Phys. , vol.58 , pp. 1063-1071
    • Mullokandov, E.1    Gejerman, G.2
  • 89
    • 77449127200 scopus 로고    scopus 로고
    • A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible
    • Tiong A., Bydder S., Ebert M., Caswell N., Waterhouse D., Spry N., et al. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys. 2010, 76:1066-1072.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.76 , pp. 1066-1072
    • Tiong, A.1    Bydder, S.2    Ebert, M.3    Caswell, N.4    Waterhouse, D.5    Spry, N.6
  • 90
    • 3042522618 scopus 로고    scopus 로고
    • Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions
    • Kim Y., Hsu I.C., Lessard E., Vujic J., Pouliot J. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys. 2004, 59:1208-1216.
    • (2004) Int J Radiat Oncol Biol Phys. , vol.59 , pp. 1208-1216
    • Kim, Y.1    Hsu, I.C.2    Lessard, E.3    Vujic, J.4    Pouliot, J.5
  • 91
    • 38149120882 scopus 로고    scopus 로고
    • HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging
    • Seppenwoolde Y., Kolkman-Deurloo I.K., Sipkema D., de Langen M., Praag J., Jansen P., et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. Radiother Oncol. 2008, 86:114-119.
    • (2008) Radiother Oncol. , vol.86 , pp. 114-119
    • Seppenwoolde, Y.1    Kolkman-Deurloo, I.K.2    Sipkema, D.3    de Langen, M.4    Praag, J.5    Jansen, P.6
  • 92
    • 72449170492 scopus 로고    scopus 로고
    • Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer
    • Yoshida K., Yamazaki H., Nose T., Shiomi H., Yoshida M., Mikami M., et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2010, 9:36-41.
    • (2010) Brachytherapy , vol.9 , pp. 36-41
    • Yoshida, K.1    Yamazaki, H.2    Nose, T.3    Shiomi, H.4    Yoshida, M.5    Mikami, M.6
  • 93
    • 77957191141 scopus 로고    scopus 로고
    • Trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321
    • Hsu I.C., Kyounghwa B., Shinohara K., Pouliot J., Purdy J., Ibbott G., et al. trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010, 78:751-758.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.78 , pp. 751-758
    • Hsu, I.C.1    Kyounghwa, B.2    Shinohara, K.3    Pouliot, J.4    Purdy, J.5    Ibbott, G.6
  • 94
    • 33748271706 scopus 로고    scopus 로고
    • High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    • Vargas C., Martinez A., Galalae R., Demanes J., Harsolia A., Schour L., et al. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis. 2006, 9:245-253.
    • (2006) Prostate Cancer Prostatic Dis. , vol.9 , pp. 245-253
    • Vargas, C.1    Martinez, A.2    Galalae, R.3    Demanes, J.4    Harsolia, A.5    Schour, L.6
  • 95
    • 77957377537 scopus 로고    scopus 로고
    • Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    • Deutsch I., Zelefsky M.J., Zhang Z., Mo Q., Zaider M., Cohen G., et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy. 2010, 9:313-318.
    • (2010) Brachytherapy. , vol.9 , pp. 313-318
    • Deutsch, I.1    Zelefsky, M.J.2    Zhang, Z.3    Mo, Q.4    Zaider, M.5    Cohen, G.6
  • 96
    • 70350499495 scopus 로고    scopus 로고
    • Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review
    • Pieters B.R., de Back D.Z., Koning C.C., Zwinderman A.H. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol. 2009, 93:168-173.
    • (2009) Radiother Oncol. , vol.93 , pp. 168-173
    • Pieters, B.R.1    de Back, D.Z.2    Koning, C.C.3    Zwinderman, A.H.4
  • 97
    • 34548047243 scopus 로고    scopus 로고
    • High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial
    • Hoskin P.J., Motohashi K., Bownes P., Bryant L., Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiother Oncol. 2007, 84:114-120.
    • (2007) Radiother Oncol. , vol.84 , pp. 114-120
    • Hoskin, P.J.1    Motohashi, K.2    Bownes, P.3    Bryant, L.4    Ostler, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.